Miles Darrin 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Miles Darrin
Chief Commercial Officer
Transactions
- Award
Restricted stock units
2021-02-10+11,000→ 11,000 total→ Common stock (11,000 underlying) - Award
Common stock
2021-02-10+44,000→ 44,000 totalExercise: $56.68Exp: 2031-02-10→ Common stock (44,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.